To study the local application effect of Liquid Mixture containing Manjishtha (Rubia cordifolia Linn.) Extract In the Treatment of Dry Eczema

Not Applicable

• Conditions: Health Condition 1: L20-L30- Dermatitis and eczema

• Registration Number: CTRI/2023/01/049126
• Lead Sponsor: Mrs Hema Vishal Nalamwar

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 February 2023

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1) Adult male or female patient diagnosed with dry eczema. ( 30 to 60 yrs)

2) Adult male or female patient diagnosed with dry eczema and not treated with any oral or external medicine in past 15 days before recruitment (if the patient is on any other oral or external medicine it shall be stopped for 15 days then the treatment which is subject matter of this study shall begin).

3) Individuals willing to sign informed consent.

Exclusion Criteria

1) Individuals allergic to manjishtha or allergic to any pharmaceutical excipient.

2) Individuals suffering from serious neurological defects, skin cancer, immunodeficiency, bullous skin disease, aplasia, albinism, weeping lesions and very severe cases (it means extensively spread lesions and not refers to signs of individual lesion).

3) Individuals not willing to sign informed consent.

4) Individuals currently participating in any other clinical study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To find out effectiveness of external application of liquid mixture extract of Manjishtha and pharmaceutical excipients on EASI score (Eczema Area and Severity Index score) in the treatment of Dry Eczema for 30 days.Timepoint: at baseline, 10 days, 20 days and 30 days

Secondary Outcome Measures

Name	Time	Method
To find out effectiveness of external application of liquid mixture containing Manjishtha Extract and pharmaceutical excipients on Improvement of Quality of Life by using Questionnaire in the treatment of Dry Eczema for 30 days.Timepoint: at base line, 10 days, 20 days and 30 days